• Email:sales@AmericanPharmaWholesale.com
  • Site Map




Please email us at Sales@AmericanPharmaWholesale.com with our item No, NDC#, UPC# or best is product link. We are located in Oceanside, California. Search over 100,000 items by Name, Item No., NDC, UPC (without dashes) or by Mfg.Name.


Menu

RX ITEM-Famotidine 10mg/ml Vial 10X4ml by Mylan Institutional

Famotidine 10mg/ml Vial 10X4ml by Mylan InstitutionalNDC 67457-0448-43 UPC/GTIN No.3-67457-44843-5 Mfg.Part No.44843Famotidine 10mg/ml Vial 10X4ml by Mylan InstitutionalThis Item Can Only Be Ordered By A Drug Mfg, Wholesaler,Pharmacy,Physician, Dentist, Podiatrist, Optometrist,Veterinarian,Naturopath,Licensed Lab, Physical Therapist & Pharmacist(scope).Famotidine 10mg/ml Vial 10X4ml by Mylan InstitutionalFamotidine 10mg/ml Vial 10X4ml by Mylan Institutional

RX ITEM-Famotidine 10mg/ml Vial 10X4ml by Mylan Institutional

$44.99$34.99

RX ITEM-NDC No. 67457-0448-43 UPC/GTIN No. 3-67457-44843-5 MPN 44843 Only Physician,Pharmacy or Licensed Facility can order this Rx Item No. Rx350892 Famotidine 10mg/ml Vial 10X4ml by Mylan Institutional Item No. 3350892 NDC No. 67457044843 UPC No. 367457448435 Other Name Pepcid,Famotidine Therapeutic Code 562812 Therapeutic Class Histamine H2-Antagonists Item Class Non Controlled Rx. Case Qnty: 36 Therapeutic Code 562812 Histamine H2-Antagonists Info Histamine H2 Receptor Antagonists [Moa],Hist

Have a question?

PEPCID - famotidine tablet, film coated

DESCRIPTION

The active ingredient in PEPCID´┐Ż (famotidine) is a histamine H2 -receptor antagonist. Famotidine is N? -(aminosulfonyl)-3-[[[2-[(diaminomethylene)amino]-4-thiazolyl]methyl]thio]propanimidamide. The empirical formula of famotidine is C8 H15 N7 O2 S3 and its molecular weight is 337.43.
Famotidine is a white to pale yellow crystalline compound that is freely soluble in glacial acetic acid, slightly soluble in methanol, very slightly soluble in water, and practically insoluble in ethanol.

Each tablet for oral administration contains either 20 mg or 40 mg of famotidine and the following inactive ingredients: hydroxypropyl cellulose, hypromellose, iron oxides, magnesium stearate, microcrystalline cellulose, corn starch, talc, titanium dioxide, and carnauba wax.

CLINICAL PHARMACOLOGY IN ADULTS

GI Effects
PEPCID is a competitive inhibitor of histamine H2 -receptors. The primary clinically important pharmacologic activity of PEPCID is inhibition of gastric secretion. Both the acid concentration and volume of gastric secretion are suppressed by PEPCID, while changes in pepsin secretion are proportional to volume output.
INDICATIONS AND USAGE

PEPCID is indicated in:

Short-term treatment of active duodenal ulcer. Most adult patients heal within 4 weeks; there is rarely reason to use PEPCID at full dosage for longer than 6 to 8 weeks. Studies have not assessed the safety of famotidine in uncomplicated active duodenal ulcer for periods of more than eight weeks.
Maintenance therapy for duodenal ulcer patients at reduced dosage after healing of an active ulcer. Controlled studies in adults have not extended beyond one year.
Short-term treatment of active benign gastric ulcer. Most adult patients heal within 6 weeks. Studies have not assessed the safety or efficacy of famotidine in uncomplicated active benign gastric ulcer for periods of more than 8 weeks.
Short-term treatment of gastroesophageal reflux disease (GERD). PEPCID is indicated for short-term treatment of patients with symptoms of GERD (see CLINICAL PHARMACOLOGY IN ADULTS, Clinical Studies).
PEPCID is also indicated for the short-term treatment of esophagitis due to GERD including erosive or ulcerative disease diagnosed by endoscopy (see CLINICAL PHARMACOLOGY IN ADULTS, Clinical Studies).
Treatment of pathological hypersecretory conditions (e.g., Zollinger-Ellison Syndrome, multiple endocrine adenomas) (see CLINICAL PHARMACOLOGY IN ADULTS, Clinical Studies).
DOSAGE AND ADMINISTRATION

Duodenal Ulcer
Acute Therapy: The recommended adult oral dosage for active duodenal ulcer is 40 mg once a day at bedtime. Most patients heal within 4 weeks; there is rarely reason to use PEPCID at full dosage for longer than 6 to 8 weeks. A regimen of 20 mg b.i.d. is also effective.

Maintenance Therapy: The recommended adult oral dose is 20 mg once a day at bedtime.

Benign Gastric Ulcer
Acute Therapy: The recommended adult oral dosage for active benign gastric ulcer is 40 mg once a day at bedtime.

Gastroesophageal Reflux Disease (GERD)
The recommended oral dosage for treatment of adult patients with symptoms of GERD is 20 mg b.i.d. for up to 6 weeks. The recommended oral dosage for the treatment of adult patients with esophagitis including erosions and ulcerations and accompanying symptoms due to GERD is 20 or 40 mg b.i.d. for up to 12 weeks (see CLINICAL PHARMACOLOGY IN ADULTS, Clinical Studies).

Dosage for Pediatric Patients <1 year of age Gastroesophageal Reflux Disease (GERD)
See PRECAUTIONS, Pediatric Patients <1 year of age.

The studies described in PRECAUTIONS, Pediatric Patients <1 year of age suggest the following starting doses in pediatric patients <1 year of age: Gastroesophageal Reflux Disease (GERD) - 0.5 mg/kg/dose of famotidine oral suspension for the treatment of GERD for up to 8 weeks once daily in patients <3 months of age and 0.5 mg/kg/dose twice daily in patients 3 months to <1 year of age. Patients should also be receiving conservative measures (e.g., thickened feedings). The use of intravenous famotidine in pediatric patients <1 year of age with GERD has not been adequately studied.

Dosage for Pediatric Patients 1-16 years of age
See PRECAUTIONS, Pediatric Patients 1-16 years of age.

The studies described in PRECAUTIONS, Pediatric Patients 1-16 years of age suggest the following starting doses in pediatric patients 1-16 years of age:

Peptic ulcer - 0.5 mg/kg/day p.o. at bedtime or divided b.i.d. up to 40 mg/day.

Gastroesophageal Reflux Disease with or without esophagitis including erosions and ulcerations - 1.0 mg/kg/day p.o. divided b.i.d. up to 40 mg b.i.d.

Famotidine 10mg/ml Vial 10X4ml by Mylan Institutional
Famotidine 10mg/ml Vial 10X4ml
Famotidine 10mg/ml Vial 10X4ml by Mylan Institutional

NDC 67457-0448-43 UPC/GTIN No.3-67457-44843-5 Mfg.Part No.44843
Famotidine 10mg/ml Vial 10X4ml by Mylan
NDC 67457-0448-43 UPC/GTIN No.3-67457-44843-5 Mfg.Part No.44843

Famotidine 10mg/ml Vial 10X4ml by Mylan Institutional
Mylan Institutional/Gen
Famotidine 10mg/ml Vial 10X4ml by Mylan Institutional

This Item Can Only Be Ordered By A Drug Mfg, Wholesaler,Pharmacy,Physician, Dentist, Podiatrist, Optometrist,Veterinarian,Naturopath,Licensed Lab, Physical Therapist & Pharmacist(scope).
Click above for Pepcid
This Item Can Only Be Ordered By A Drug Mfg, Wholesaler,Pharmacy,Physician, Dentist, Podiatrist, Optometrist,Veterinarian,Naturopath,Licensed Lab, Physical Therapist & Pharmacist(scope).

Famotidine 10mg/ml Vial 10X4ml by Mylan Institutional
Mylan Institutional/Gen
Famotidine 10mg/ml Vial 10X4ml by Mylan Institutional

Famotidine 10mg/ml Vial 10X4ml by Mylan Institutional
Famotidine 10mg/ml Vial 10X4ml
Famotidine 10mg/ml Vial 10X4ml by Mylan Institutional